MedGenome has announced a majority investment in Gujarat-based pathology laboratory chain, Green Cross Genetics Lab, marking a strategic step to expand its diagnostic footprint in western India.
Green Cross, founded by Vinod Patel, has been serving patients for over three decades. It currently operates 17 laboratories and 35 collection centres across Gujarat, all managed under the guidance of senior pathology experts committed to precision and reliability. The promoters will continue to lead the business as it enters its next phase of growth.
Combining Strengths in Genomics and Diagnostics
MedGenome operates South Asia’s largest CAP-accredited end-to-end multiomics laboratory and leverages advanced AI and machine learning tools to deliver data-driven genetic insights. These insights help clinicians diagnose and manage complex diseases with greater accuracy.
Commenting on the development, Dr. Vedam Ramprasad, CEO, MedGenome, stated,
“This partnership will strengthen MedGenome’s market presence in Gujarat, allowing us to better serve a broader population. It reinforces our commitment to improving access to affordable omics solutions, especially in Tier 2 and Tier 3 cities. With Green Cross’s three-decade legacy of trust and quality diagnostics, this partnership perfectly aligns with our mission to harness genomics for early and accurate disease detection and management.”
He further added that MedGenome is working to position Indian genomics on the global stage. The company will continue to innovate and create scalable solutions for diverse healthcare markets worldwide.
Enhancing Diagnostic Reach and Capabilities
Expressing enthusiasm for the collaboration, Vinod Patel, Promoter and Director, Green Cross Genetics Lab, said,
“We are excited to partner with MedGenome, a leader in genomic testing, to broaden our diagnostics service offerings. Both companies share a strong legacy of trust and quality. This partnership merges our infrastructure, technology, distribution, and clinical expertise with MedGenome’s world-class genomics capabilities.”
He highlighted that combining Green Cross’s portfolio of over 800 diagnostic tests and a team of more than 500 professionals with MedGenome’s advanced genomics platform will create a more comprehensive service menu for clinicians and patients nationwide.
Driving Access to Advanced Testing Across India
As reported by Express Healthcare, the partnership aims to integrate genomics more effectively into diagnostics. It will provide patients with clinically actionable testing services. MedGenome and Green Cross are merging cutting-edge genetic technologies with strong diagnostic networks. This aims to make precision healthcare more accessible and impactful across India.